WHO Approves World's First RTS,S Vaccine Against Parasitic Diseases
WHO authorised the world's first vaccine against any parasitic diseases on October 6, bringing three decades of scientific work to completion. GlaxoSmithKline produced RTS,S (brand name Mosquirix), which substantially decreases the risk of severe illness in malaria-infected children. Since 2019, it has been used as part of a trial study in parts of Africa. India's Bharat Biotech is expected to be the only global vaccine manufacturer by 2029.